Raising funds for semiconductor equipment and R&D through privately placed convertible bonds with stock acquisition rights
First written in FY2020-Q3. 4 of 7 entries say "Advanced", first in FY2023-Q1. Latest entry: FY2027-H1.
23 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Exercise of the stock acquisition rights attached to the 2028-maturity euro-yen convertible bonds with stock acquisition rights increased total shares issued by 6,952,587, capital by ¥12,490 million and capital reserves by ¥12,490 million.」
Exercise of rights attached to the 2028-maturity convertible bonds with stock acquisition rights progressed during the interim period, resulting in substantial increases in shares issued, capital and capital reserves. The balance of the bonds on the balance sheet was zero. - FY2026AdvancedAnnual report
「For the 2028-maturity euro-yen convertible bonds with stock acquisition rights issued by the company on 23 June 2023, 2,498 stock acquisition rights were exercised between the end of the fiscal year and 13 June 2026, increasing capital by ¥12,490 million, capital reserves by ¥12,490 million and common shares by 6,952 thousand shares.」
Following the end of the fiscal year, large-scale exercise of rights attached to the 2028-maturity convertible bonds with stock acquisition rights progressed, resulting in specific increases in shares and capital. - FY2024-Q1Issuance of new euro-yen convertible bonds with stock acquisition rightsAnnual report
「The convertible bonds with stock acquisition rights issued under the Companies Act during the first quarter were as follows: 2028-maturity euro-yen convertible bonds with stock acquisition rights.」
The company disclosed that it issued 2028-maturity euro-yen convertible bonds with stock acquisition rights on 23 June 2023, with an outstanding balance of ¥25,000 million, a conversion price of ¥4,020 per share and an exercise period from 7 July 2023 to 9 June 2028. - FY2023-Q2AdvancedAnnual report
「The conversion of the convertible bonds with stock acquisition rights increased capital and capital surplus by ¥1,067 million each.」
The conversion of the convertible bonds with stock acquisition rights increased capital and capital surplus by ¥1,067 million each. The balance of the convertible bonds with stock acquisition rights on the balance sheet was zero. - FY2023-Q1AdvancedAnnual report
「Increase or decrease in total shares issued 888,199」
Following the exercise of stock acquisition rights and stock acquisition rights attached to convertible bonds with stock acquisition rights, 888,199 shares were issued during the first quarter. The outstanding balance of the convertible bonds with stock acquisition rights also declined from ¥2,134 million at the end of the previous fiscal year to ¥1,295 million. - FY2020RestatedAnnual report
「The balance of the second unsecured convertible bonds with stock acquisition rights was ¥3,734.976 million, and the exercise period for the stock acquisition rights was from 6 February 2020 to 31 January 2025.」
The annual disclosure reconfirmed the outstanding balance of ¥3,734 million, the conversion period and the number of shares subject to conversion, among other details, for the privately placed convertible bonds with stock acquisition rights. - FY2020-Q3First statedAnnual report
「At a board meeting held on 17 January 2020, the company resolved to issue convertible bonds with stock acquisition rights through a private placement (the “Bonds with Stock Acquisition Rights,” the bond component being the “Bonds” and the stock acquisition rights component being the “Stock Acquisition Rights”). Payment was completed on 5 February 2020.」
Total issue amount: ¥3,734.976 million; redemption date: 4 February 2025; conversion price: ¥949 per share. The proceeds were scheduled to be used for production equipment for quartz, ceramics and power semiconductor substrates, and for R&D investment in semiconductor silicon wafers.